ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Medicare Will Cover Patient Care Costs For All Phases Of Cancer Treatment Trials.

September 1, 2000

Obituary: Michale Keeling, of M.D. Anderson.

January 2, 2004

NIH Bias Against Young Investigators Threatens To “Deprime The Pump,” Zerhouni Says.

February 15, 2008

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

June 16, 1995

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994